The EGFR R521K polymorphism has been shown to reduce the activity of EGFR; however, the association between EGFR R521K polymorphism and the risk of cancer remains inconclusive; therefore we performed a meta-analysis to evaluate the relationship between EGFR R521K polymorphism and susceptibility to cancer. Our results suggest that the EGFR R521K polymorphism is not associated with risk of cancer, but the different chemosensitivity to anticancer drugs may need further investigation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221867 | PMC |
| http://dx.doi.org/10.1155/2014/312102 | DOI Listing |
Publication Analysis
Top Keywords
egfr r521k
20
r521k polymorphism
20
risk cancer
12
polymorphism risk
8
cancer egfr
8
egfr
6
r521k
5
polymorphism
5
meta-analysis relations
4
relations egfr
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!